Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
7.60
+0.74 (10.79%)
Aug 13, 2025, 4:00 PM - Market closed
Enanta Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Enanta Pharmaceuticals stock ranges from a low of $18 to a high of $25. The average analyst price target of $20.75 forecasts a 173.03% increase in the stock price over the next year.
Price Target: $20.75 (+173.03%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Enanta Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Maintains $24 → $25 | Buy | Maintains | $24 → $25 | +228.95% | Aug 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +163.16% | Jul 28, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $23 → $24 | Buy | Maintains | $23 → $24 | +215.79% | Jun 3, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $21 → $23 | Buy | Maintains | $21 → $23 | +202.63% | May 14, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $21 | Buy | Reiterates | $21 | +176.32% | Feb 11, 2025 |
Financial Forecast
Revenue This Year
64.28M
from 67.64M
Decreased by -4.96%
Revenue Next Year
66.89M
from 64.28M
Increased by 4.05%
EPS This Year
-4.59
from -5.48
EPS Next Year
-3.48
from -4.59
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 68.8M | 73.4M | 69.7M | ||
| Avg | 64.3M | 66.9M | 66.5M | ||
| Low | 60.5M | 57.3M | 62.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.7% | 14.2% | 4.2% | ||
| Avg | -5.0% | 4.1% | -0.6% | ||
| Low | -10.6% | -10.8% | -6.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -4.35 | -2.21 | -1.47 | |
| Avg | -4.59 | -3.48 | -1.43 | |
| Low | -4.93 | -4.73 | -1.37 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.